This post is a brief outline of my physical "Thyroid Therapy Transformation," a glimpse into my personal life and how symptoms and body composition changed in response to changes in thyroid therapy and diet. You can see my favorite colors are pinks and blues. And it also shows many hairstyle transformations, ha ha! This post … Continue reading My body composition before and during thyroid therapy
As part of my post on "The thyroid gland is a T3 shield," I reviewed a research article by Ingbar and team from 1982. Wow. What a treasure. The title of this article is "Elevated serum thyroxine concentration in patients receiving 'replacement' doses of levothyroxine." Just look at that title. They began their title with … Continue reading Ingbar and Braverman’s historic study of LT4 monotherapy
In 2011, Gullo's research team published a landmark study in thyroid therapy titled "Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients." Gullo and colleagues examined the TSH, FT3 and FT4 levels and the FT3:FT4 ratios of 1,811 thyroidless patients on levothyroxine (LT4) monotherapy and compared them with 3,875 healthy controls. Gullo's study shook the … Continue reading Gullo: LT4 monotherapy and thyroid loss invert FT3 and FT4 per unit of TSH
I would like to applaud a 2019 article by Mitsuru Ito and colleagues from the Center for Excellence in Thyroid Care at Kuma Hospital, Kobe, Japan. Dear researchers, your article, "Thyroid function related symptoms during monotherapy in athyreotic patients" showcased research on Free T3 levels and symptoms that is potentially meaningful to the life and … Continue reading Japanese thyroid scientists examine symptoms in relation to FT3 and TSH
A clinical trial comparing Armour Thyroid (NDT) and Levothyroxine (LT4) is now recruiting patients in the United States. The sponsor of the study is Allergan, the makers of Armour Thyroid in the United States. They hope to recruit 220 patients at multiple locations listed on the clinical trial website. In this post, I provide what … Continue reading New clinical trial of Armour Thyroid is recruiting U.S. patients
